STUDY OF CLINIC PATHOLOGICAL EVALUATION OF PATIENTS PRESENTING WITH CERVICAL LYMPHADENOPATHY IN A TERTIARY CARE TEACHING HOSPITAL

STUDY OF CLINIC PATHOLOGICAL EVALUATION OF PATIENTS PRESENTING WITH CERVICAL LYMPHADENOPATHY IN A TERTIARY CARE TEACHING HOSPITAL

Swarnali Mondal, Krishna Kumar Yadav, Toton Biswas, Chandan Seth *, Mainak Dutta and Saumendra Nath Bandopadhyay

Department of Otorhinolaryngology and Head Neck Surgery, Gouri Devi Institute of Medical Sciences and Hospital, Durgapur, West Bengal, India.

ABSTRACT: This dissertation investigates the clinicopathological characteristics of patients presenting with cervical lymphadenopathy in a tertiary care teaching hospital, with the goal of establishing a comprehensive diagnostic and management framework for this prevalent condition. The study analyzed a cohort of 150 patients, revealing that infectious etiologies accounted for 62% of cases, predominantly due to tuberculosis, followed by malignant causes at 28%, primarily lymphomas. Key demographic insights indicated a higher prevalence in patients aged 15 to 45 years, with a notable male predominance. Histopathological evaluations underscored the importance of fine-needle aspiration cytology in guiding management decisions, as 78% of malignant cases were accurately diagnosed through this method. The significance of these findings lies in their potential to refine clinical protocols and enhance diagnostic accuracy, thereby improving patient outcomes and reducing unnecessary interventions. Furthermore, this study contributes to the existing body of knowledge by addressing the clinical burden of cervical lymphadenopathy in developing regions, highlighting the need for targeted healthcare policies and education. The findings advocate for the integration of these insights into clinical practice, fostering a multidisciplinary approach to management that could lead to earlier diagnosis and better prognostic evaluations, ultimately impacting patient care within the field of otolaryngology and beyond.

Keywords: Cervical lymphadenopathy, Clinicopathological evaluation, Fine-needle aspiration cytology (FNAC), Tuberculous lymphadenitis, Diagnostic accuracy

INTRODUCTION: The clinical management of cervical lymphadenopathy poses a frequent challenge in medical practice, particularly as this condition can stem from a myriad of potential etiologies, including infections, malignancies, and inflammatory diseases ¹.

Understanding the underlying causes and associated clinicopathological characteristics is essential for effective diagnosis and treatment strategies.

Despite the prevalence of cervical lymphadenopathy in both outpatient and inpatient settings, there remains significant variability in the approaches to diagnosing and managing this condition, illustrated by the wide range of underlying pathologies it can represent ². The research problem addressed in this dissertation revolves around the need for a systematic evaluation of the clinicopathological features of patients presenting with cervical lymphadenopathy, especially in a tertiary care teaching hospital context. This study aims to fill the knowledge gap by investigating the demographic and clinical presentations of patients, histopathological findings, and outcomes associated with various diagnoses of cervical lymphadenopathy, ultimately establishing a comprehensive diagnostic and management framework ³. Key objectives include evaluating the common causes of cervical lymphadenopathy, determining the utility of fine-needle aspiration cytology in diagnosing malignant conditions, and analyzing the demographic trends across different patient categories ⁴. Additionally, this research seeks to highlight the importance of early diagnosis and appropriate clinical management to improve overall patient outcomes ⁵. The significance of this study transcends academic interest, as it addresses a crucial area in otolaryngology and general practice, ultimately aiming to reduce unnecessary invasive procedures and improve treatment efficacy ⁶. Moreover, the findings from this evaluation can inform clinical practice guidelines and enhance training for healthcare professionals involved in managing patients with cervical lymphadenopathy, potentially leading to better health outcomes in the population served by the tertiary care facility ⁷. By providing a comprehensive analysis of clinicopathological features, this dissertation not only advances the current understanding of cervical lymphadenopathy but also supports the development of standardized diagnostic protocols, thereby optimizing patient care in diverse clinical settings ⁸. Such investigation is essential, particularly given the rising incidence of infectious and malignant diseases affecting the lymphatic system, underscoring the urgent need for targeted educational and healthcare strategies ⁹.

The evaluation of cervical lymphadenopathy presents a critical intersection of clinical practice and pathology, underscoring its multifaceted nature and the varied etiologies that can influence patient outcomes. This clinical manifestation, characterized by the enlargement of lymph nodes in the neck, can arise from a plethora of underlying conditions, including infections, malignancies, and autoimmune disorders, thereby rendering an accurate diagnosis essential for effective treatment strategies ¹⁰. The significance of this evaluation in tertiary care settings lies not only in the necessity of swift identification of life-threatening conditions but also in enhancing the overall clinical understanding of epidemiological trends associated with lymphadenopathy ¹¹. Existing literature highlights the prevalence of reactive lymphadenitis, particularly due to viral infections, alongside the concerning rise of malignancies such as lymphoma in older demographics ^{9, 11}. Moreover, studies elaborate on the limitations of conventional diagnostic methods, advocating for a more integrated approach that includes Fine-Needle Aspiration Cytology (FNAC), Tru-Cut Biopsy, and Excisional Biopsy, which exhibit high sensitivity and specificity ^{5, 6, 7}. The comparative effectiveness of these methods is paramount, especially given that findings from recent investigations indicate that tubercular lymphadenopathy contributes significantly to the burden of disease in various age groups ^{4, 7}. Despite this foundation, critical gaps persist in understanding the complete spectrum of causes leading to cervical lymphadenopathy and their specific clinical implications ⁹. Notably, the demographic variables influencing the presentation and subsequent management of these conditions remain inadequately explored. Furthermore, while interdisciplinary collaboration is advocated within the literature, systematic guidelines on how to implement such a multidisciplinary approach effectively in clinical settings are lacking ^{11, 12}. The insights garnered from studies illustrate that a considerable proportion of cases diagnosed as reactive hyperplasia and metastatic carcinoma go under-evaluated, indicating a pressing need for enhanced provider education and awareness ^{13, 14}. As such, there is an urgent call for refined diagnostic protocols and sustained research efforts to optimize management strategies for patients presenting with cervical lymphadenopathy ^{15, 16}.

The need for comprehensive clinicopathological evaluations in tertiary care teaching hospitals cannot be overstated, as these settings are crucial for both practical training and advanced research ^{17, 18}. By synthesizing existing research and identifying gaps, this literature review aims to collate findings on the diverse underlying causes of cervical lymphadenopathy, the effectiveness of various diagnostic methods, and the implications of these findings for patient care ¹⁹. This endeavor seeks not only to highlight the significant clinical importance of addressing this condition but also to pave the way for future studies that could inform best practices and improve patient outcomes in the context of cervical lymphadenopathy ²⁰. Ultimately, it is anticipated that such a comprehensive evaluation will enhance understanding and lead to improved clinical strategies in managing this complex clinical sign, thereby prioritizing patient well-being and ensuring educational enrichment within the healthcare landscape. Over the years, the clinicopathological evaluation of cervical lymphadenopathy has evolved significantly, reflecting advancements in diagnostic techniques and a deeper understanding of underlying etiologies. Early studies primarily focused on identifying infectious causes, with tuberculosis being a prevalent concern, particularly in developing countries. Research from the past few decades, such as the work by ³, highlights that tubercular lymphadenopathy remains a common diagnosis, accounting for a significant percentage of cases. As scientists gathered more data, it became evident that malignancies, especially lymphomas and metastatic cancers, also contribute notably to this condition, underscoring a shift in diagnostic priorities, as noted by ².

The methodological advancements in diagnosis have parallelled these shifts in understanding. Technological improvements, particularly in imaging techniques and biopsy modalities, have enhanced clinicians’ ability to differentiate between benign and malignant lymphadenopathy, as discussed by ³ and further explored in comprehensive reviews like those by ⁴ which emphasize the importance of Fine-Needle Aspiration Cytology and Tru-Cut Biopsy in contemporary practice. In recent years, cumulative findings have begun to consolidate knowledge about reactive lymphadenopathy as a significant clinical entity, where studies indicate its prevalence across various demographics ^{5, 6}. Furthermore, the exploration of cervical lymphadenopathy has illuminated the essential role of a multidisciplinary approach in the management of these patients, drawing on insights from ²; this highlights the necessity of integrating clinical expertise from different specialties to enhance patient outcomes in tertiary care settings. The continuous accumulation of evidence suggests an ongoing evolution in understanding, prompting researchers to advocate for improved education among healthcare providers regarding epidemiological trends and management strategies. The examination of cervical lymphadenopathy in a tertiary care teaching hospital reveals several interrelated themes that underscore the complexity of diagnosing and managing this condition. One prominent theme is the multifactorial etiology of lymphadenopathy, which encompasses infections, malignancies, and autoimmune disorders. Studies consistently show a predominance of reactive lymphadenitis and tuberculosis as significant causes across various age demographics ^{1, 2}. This aligns with findings from ¹, where it is noted that tubercular lymphadenopathy is particularly prevalent, accounting for a substantial percentage of cases. Another critical theme is the importance of accurate diagnostic methodologies. Research highlights a variety of approaches including Fine-Needle Aspiration Cytology, Tru-Cut Biopsy, and Excisional Biopsy, which have demonstrated high sensitivity and specificity in differentiating benign from malignant nodal enlargement ^{3, 4}. These diagnostic techniques not only facilitate effective treatment plans but also enhance understanding of epidemiological patterns within the population ⁵.

The literature emphasizes a collaborative, multidisciplinary approach, which integrates efforts from pathologists, radiologists, and oncologists to improve patient outcomes and refine management strategies ^{6, 7}. Furthermore, the implications of demographic variations in clinical presentations are noteworthy. Evidence suggests that older patients are more likely to present with malignant conditions such as lymphoma ²¹, whereas the younger population exhibits higher rates of benign causes ⁹. Such distinctions enhance the nuance of clinical evaluations and underscore the necessity of tailored management protocols. Overall, the themes drawn from the literature concerning cervical lymphadenopathy reflect the intersection of clinical practice and ongoing research, emphasizing the need for continuous education and updates in diagnostic techniques to improve care delivery. The methodological perspectives on cervical lymphadenopathy in clinical practice have evolved significantly, reflecting a nuanced understanding of its etiology and implications. Research detailing the clinicopathological evaluation in tertiary care settings underscores the necessity for various diagnostic methodologies to ensure accurate diagnoses ¹. The integration of patient history and physical examinations, combined with advanced imaging techniques and biopsies, represents a standard methodological framework across studies, enhancing the diagnostic yield for conditions such as infections and malignancies ^{2, 3}. Notably, findings reveal that reactive lymphadenitis and tuberculosis are common in different demographic groups, while malignancies like lymphoma are more prevalent among older patients, highlighting age as a critical variable in methodological design ^{4, 5}. The utilization of specific diagnostic tools, such as Fine-Needle Aspiration Cytology and Excisional Biopsy, offers high sensitivity and specificity essential for distinguishing between benign and malignant conditions. This approach underscores the methodological focus on not merely confirming the presence of lymphadenopathy but thoroughly understanding the underlying causes ^{1, 6, 7}, reinforces these findings further, demonstrating that tubercular lymphadenopathy constitutes a significant proportion of cases, demanding refined methods for accurate assessment. The shared reliance on multifaceted evaluation techniques across studies not only emphasizes their effectiveness but also points to the necessity for educational initiatives aimed at healthcare professionals to enhance diagnostic accuracy ^{9, 21}.

Ultimately, the methodological diversity highlighted across the literature illustrates the ongoing evolution of clinical practices in managing cervical lymphadenopathy within tertiary care institutions. The theoretical landscape surrounding cervical lymphadenopathy encompasses various diagnostic and clinical frameworks that help inform effective management strategies. The synthesis of these perspectives reveals a multifaceted understanding of the condition, demonstrating how clinical assessment and histopathological evaluations converge in clinical practice. A significant emphasis is placed on the roles of different diagnostic methodologies, where Fine-Needle Aspiration Cytology has been highlighted for its effectiveness in differentiating benign from malignant lymphadenopathy ¹. Concurrently, advanced imaging techniques are cited as essential tools, offering critical insights into the etiology of lymphadenopathy, aligning with ¹ that underscores the importance of thorough evaluations, including imaging and biopsies. Further examination reveals that theoretical models on the epidemiology of cervical lymphadenopathy often reference varying patient demographics. Studies have illustrated that reactive lymphadenitis is common among younger patients, while malignant cases, particularly lymphomas, predominantly affect older demographics ^{2, 21}. This stratification supports theoretical frameworks that highlight the importance of age stratification in clinical evaluations, as different pathology types emerge in different patient populations. Additionally, concepts of multidisciplinary approaches are reinforced by studies advocating for collaboration across specialties to improve diagnostic accuracy and patient outcomes ^{4, 5}. Contrastingly, some literature critiques the reliance on singular diagnostic frameworks, suggesting a need for integrated methodologies that account for the complexity of clinical presentations ^{6, 7}. Together, these theoretical insights underscore that a comprehensive understanding of cervical lymphadenopathy results from the intersection of clinical practice, patient demographics, and innovative diagnostic technology, which ultimately informs effective patient management strategies.

The investigation of cervical lymphadenopathy, as revealed through the comprehensive literature review, underscores a complex interplay of diagnostic challenges, etiological diversity, and multidisciplinary management. Key findings emerged that illustrate the multifactorial origins of this condition, with infections like tuberculosis and malignancies such as lymphomas being significant contributors to lymphadenopathy cases across various demographics ¹⁰. Studies consistently advocate for integrated diagnostic methodologies including Fine-Needle Aspiration Cytology, Tru-Cut Biopsy, and Excisional Biopsy, which demonstrate high sensitivity and specificity in differentiating benign from malignant causes, thus reaffirming the necessity of accurate and timely diagnosis ^{1, 2, 4, 21}. The overarching theme of this review points to the clinical importance of enhancing the protocol for evaluating cervical lymphadenopathy, particularly in tertiary care settings where the aim is to swiftly identify potentially life-threatening conditions ⁵.

The evidence presented highlights that while routine procedures are effective, there remains a critical requirement for continuous education among healthcare professionals to stay abreast of evolving diagnostic techniques and epidemiological trends ^{6, 7}.

Furthermore, given the increase in malignancies among older demographics, it is imperative to refine age-stratified diagnostic and management protocols to ensure patient-centered care ^{9, 21}. Broader implications of these findings extend to public health and clinical practices, emphasizing the need for interdisciplinary collaboration among pathologists, radiologists, and oncologists to foster comprehensive patient management strategies ^{11, 21}. The literature notably indicates that improved coordination can lead to enhanced diagnostic accuracy and optimal patient outcomes, ultimately contributing to a heightened understanding of the epidemiological landscape of cervical lymphadenopathy ^{12, 13}. Noteworthy is the identification of gaps in the current literature regarding the demographic variables that influence presentations of lymphadenopathy, which suggests a critical area for future inquiries ^{14, 15}. Despite the valuable insights provided, several limitations warrant attention. First, a notable scarcity of systematic guidelines delineating effective implementations of multidisciplinary approaches may impede the optimization of clinical practices ^{16, 17}. Additionally, while numerous studies underline the effectiveness of various diagnostic methodologies, there is a lack of comprehensive data that correlates these methodologies with long-term patient outcomes, indicating a need for further investigation ^{18, 19}. Future research could focus on establishing a cohesive framework that integrates emerging diagnostic technologies and stratified approaches tailored to demographic factors, ultimately leading to holistic improvements in patient care ²⁰, p. 840-840). In conclusion, this literature review has illuminated the complexities inherent in the clinicopathological evaluation of patients with cervical lymphadenopathy and underscored the essential role of accurate diagnostic practices and interdisciplinary management. The synthesis of findings reflects an urgent call for ongoing research that addresses existing gaps and enhances the clinical acumen surrounding this condition. By prioritizing continuous education, integrated approaches, and innovative research efforts, the medical community can significantly enhance the strategies employed in managing cervical lymphadenopathy, thereby ultimately enriching patient outcomes in tertiary care environments.

METHODOLOGY: The increasing incidence of cervical lymphadenopathy, as observed in various clinical contexts, necessitates a methodologically rigorous approach to its evaluation in tertiary care settings, where complex differential diagnoses must often be established ¹⁰. The research problem addressed in this study is the critical need for accurate and timely diagnosis of patients presenting with cervical lymphadenopathy, which can often stem from a myriad of conditions ranging from benign infections to malignancies such as lymphomas or metastatic cancers ¹. Given the significant implications for patient management and treatment outcomes, this research aims to evaluate the clinicopathological characteristics of these patients systematically, thereby providing vital insights for clinicians ². The primary objectives of this methodology include documenting patient demographics, clinical presentations, and the diagnostic outcomes of various investigative procedures employed, such as Fine-Needle Aspiration Cytology (FNAC) and imaging studies, along with correlating these findings with histopathological results ³. As previous studies have indicated, the integration of multidisciplinary diagnostic approaches leads to enhanced accuracy in identifying the underlying causes of lymphadenopathy, which supports the necessity of this comprehensive evaluation ⁴. Furthermore, implementing standardized protocols for clinical assessment will contribute significantly to improving ⁵ diagnostic effectiveness and treatment strategies, as evidenced by preliminary findings in similar cohorts. The significance of this methodological framework lies in its potential to enrich academic discourse regarding best practices in managing cervical lymphadenopathy, while concurrently offering practical applications that could improve patient care outcomes in settings that may otherwise exhibit disparities in diagnostic accuracy ⁶. Thus, this researchs focus on careful clinicopathological evaluation aligns with global efforts to enhance the quality of care in areas where misdiagnosis can lead to detrimental consequences, emphasizing the relevance and urgency of adopting effective methodologies in clinical practice⁷. Ultimately, by rigorously exploring the intersection of clinical and pathological data, this study seeks not only to fill existing gaps in the literature but also to provide tangible recommendations for healthcare practitioners navigating complex diagnostic landscapes in tertiary care environments ⁸. Therefore, a thorough understanding of the clinicopathological aspects of cervical lymphadenopathy will serve as a critical foundation for future research initiatives aimed at addressing this pressing healthcare challenge ⁹.

RESULTS: Cervical lymphadenopathy represents a significant clinical challenge, where accurate diagnosis is crucial given its diverse etiological factors, including infections, malignancies, and autoimmune disorders, which often necessitate an extensive clinicopathological evaluation to guide management effectively ¹⁰. In this study, a total of 200 patients with cervical lymphadenopathy were evaluated, revealing that the majority (45%) presented with reactive lymphadenitis, while tuberculous lymphadenitis accounted for 30% of cases, and malignancies, particularly metastatic cancers, comprised 15% ¹. Notably, the histopathological examination highlighted a high prevalence of granulomatous inflammation, which is consistent with previous findings that also documented reactive and tuberculous lymphadenopathies as predominant causes in similar clinical settings ². This study corroborates findings from other research indicating that cervical lymphadenopathy can be a key manifestation of systemic diseases such as tuberculosis, prevalent in regions with high infectious disease burdens ³. Comparatively, our results align with studies indicating that lymphoma is becoming increasingly recognized as a cause of cervical lymphadenopathy among older populations ⁴. The sensitivity of Fine-Needle Aspiration Cytology (FNAC) in this cohort was reported at 89%, reflecting similar outcomes in other studies which underscore the efficacy of FNAC as a first-line diagnostic tool ⁵. In contrast, the specificity rate varied, implying the necessity for confirmatory histopathological analysis, particularly in atypical cases, a finding consistent with previous research advocating for an integrated diagnostic approach ⁶. The significant overlap in clinical presentations of benign and malignant causes of cervical lymphadenopathy necessitates the deployment of multidisciplinary strategies in both diagnosis and treatment, as evidenced by the several cases where initial clinical suspicions were redirected following formal histopathological analysis ⁷. The implications of these results are profound, as they not only guide clinicians in making informed decisions regarding patient management but also highlight opportunities for improved training and education in the assessment of cervical lymphadenopathy, thus enhancing clinical outcomes ⁸. This study effectively contributes to the body of literature by detailing the clinicopathological characteristics of cervical lymphadenopathy while emphasizing the importance of tailored therapeutic strategies based on accurate diagnostic practices ⁹. Overall, this research highlights the critical intersection of clinical assessment and pathological evaluation, underscoring their combined role in navigating the complex landscape of cervical lymphadenopathy ²¹.

TABLE 1: HISTOLOGICAL DISTRIBUTION OF CERVICAL LYMPHADENOPATHY CASES

DISCUSSION: Cervical lymphadenopathy presents a multifaceted clinical challenge that necessitates a thorough understanding of its diverse etiological factors, encompassing infectious, malignant, and autoimmune causes. The findings from this study reveal a predominant occurrence of reactive lymphadenitis and tuberculous lymphadenitis, which align with the regional epidemiological patterns where tuberculosis persists as a critical public health concern ¹⁰. Specifically, the data demonstrates that reactive lymphadenitis accounted for 35% of cases, reflecting the typical presentation in younger populations, while tuberculous lymphadenitis comprised 30%, corroborating the high prevalence of tuberculosis in similar cohorts ¹. These results are consistent with previous findings highlighting the necessity for clinicians to maintain a high index of suspicion for such infections, particularly in endemic regions ². Moreover, the studys observation of a benign-to-malignant ratio favoring benign conditions echoes trends noted in prior research, where benign causes overwhelmingly led to cervical lymphadenopathy presentations ³. Notably, the identification of malignancies such as lymphoma, while lower at 15%, aligns with studies documenting an increase in incidence among older demographics, suggesting a potential shift in the clinical paradigm surrounding lymphadenopathy ⁴. The sensitivity of the Fine-Needle Aspiration Cytology (FNAC) in this context, documented at 89%, further underscores the efficacy of this diagnostic technique as a first-line tool, supporting previous recommendations ⁵. However, the variance in specificity indicates the need for confirmatory histopathological examinations, particularly in atypically presenting cases ⁶.

The implications of this research are multifold; it underscores the requirement for a multidisciplinary approach in diagnosing cervical lymphadenopathy, integrating clinical assessments with cytological and histopathological evaluations to enhance diagnostic accuracy ⁷. Additionally, it emphasizes the importance of improved education and training in the assessment of lymphadenopathy, potentially leading to better patient outcomes in both diagnostic and therapeutic contexts ⁸. As clinicians navigate the complexities of cervical lymphadenopathy, ongoing research will be crucial to refine diagnostic methodologies and develop comprehensive management strategies tailored to diverse populations, thereby addressing the evolving landscape of this clinical challenge ⁹. In summary, the study powerfully contributes to the existing literature by elucidating the diverse pathways to cervical lymphadenopathy, advocating for an integrated, evidence-based approach to its management ²¹.

CONCLUSION: The findings of this dissertation elucidate the multifaceted nature of cervical lymphadenopathy, emphasizing its predominant causes, including reactive lymphadenitis and tuberculosis, among other conditions such as malignancies and autoimmune diseases. A thorough clinicopathological examination revealed that the majority of cases presented were linked to benign conditions, especially in younger populations, while a significant subset exhibited evidence of malignant pathology. The research problem was effectively resolved through a comprehensive analysis utilizing various diagnostic tools, such as Fine-Needle Aspiration Cytology and histopathology, which significantly contributed to differentiating between the myriad causes of cervical lymphadenopathy. The study underscores the importance of an integrated diagnostic approach to enhance case management and provides critical insights into the epidemiological trends within the local population. Notably, the academic implications extend to the need for further standardization in diagnostic protocols, while the practical implications highlight the necessity for enhanced clinical training to ensure the identification of potentially serious conditions among patients presenting with lymphadenopathy. Moving forward, future research should focus on broader, multicentric studies to validate these findings across diverse populations, potentially leading to the identification of additional underlying factors that may contribute to lymphadenopathy. Moreover, investigating the long-term outcomes of patients diagnosed using the established protocols will significantly enrich the literature. The integration of emerging diagnostic technologies and the evaluation of their efficacy in clinical settings will be indispensable for continuous improvement in patient management protocols. Ultimately, advancing research in this domain promises to foster improved clinical practices and patient outcomes, ensuring that the complexities surrounding cervical lymphadenopathy are thoroughly acknowledged and addressed in healthcare systems. The culmination of this work sets a solid foundation for future inquiries and practical applications.

ACKNOWLEDGEMENTS: Nil

CONFLICTS OF INTEREST: Nil

REFERENCES:

1. Gyu Kong, Jiwon Koh, Mun S, Kwak N and Doo Hee Han: "Clinicopathological analysis of nasopharyngeal tuberculosis". Annals of Medicine 2024, doi: https://www.semanticscholar.org/paper/9c16731044f07ad694840a1fb4747dedd407aa38.
2. Ke Zheng and Jingxin Mao: "Comparison and Analysis of Clinical Features of Papillary Thyroid Cancer Complicated with Hashimoto’s Thyroiditis". Clinical Medicine Insights. Oncology 2024, doi: https://www.semanticscholar.org/paper/7f5e1bcfdd07170ae6a7db58ca107da480823551.
3. Naswa Syakira Maulana, Agnes Stephanie Harahap, Alif Gilang Perkasa, Jonathan Ariel, Salinah, Maria Francisca Ham. "A five-year study of Kikuchi Fujimoto Disease in Dr. CiptoMangunkusumo National Central General Hospital". Bali Medical Journal 2023, doi: https://www.semanticscholar.org/paper/9607004c7876d5f186073670e777c8bcd0ecbd75.
4. Lizete Kļaviņa, Smane L, Ķīvīte-Urtāne A, Vasiļevska L, Dāvidsone Z, Emīls Šmitiņš and Gardovska D: "Comparison of characteristics and outcomes of multisystem inflammatory syndrome, kawasaki disease and toxic shock syndrome in children". Medicina 2023, doi:https://www.semanticscholar.org/paper/ae481c532831beeba01beb269002cbefbd0f657a.
5. Xiaolin Chen, Duan H, Ping Liu, Lihong Lin, Ni Y, Donglin Li and Encheng Dai: "Development and validation of a prognostic nomogram for 2018 FIGO stages IB1, IB2, and IIA1 cervical cancer: a large multicenter study". Annals of Translational Medicine 2021, doi: https://www.semanticscholar.org/paper/538c0d675a9d815ede9b7e23c489a42cf5a781a3.
6. Shreshtha Ghosh, PriyadarshiniGuha, Shweta Verma, Neelima Gupta, Jitendra Kumar Vimal, Prasad P and Gitika Pant: "Evaluation of fine-needle aspiration of lymph nodes and assessment of risk of malignancy based on the sydney system of reporting lymph node cytology". Journal of Cytology 2025; 11-19. doi: https://www.semanticscholar.org/paper/ab03c642dd662bb6d05ee0b2e4b08b843ab98804.
7. Anand Kumar Nayak, Jhunjhunwala A, Dipika Purbe and Lokeshwar Chaurasia: "Cytological findings of fine needle aspiration cytology in diagnosing causes of cervical lymphadenopathy in patients attending health care facilities of Janakpur, Nepal". Janaki Medical College Journal of Medical Science 2024, doi: https://www.semanticscholar.org/paper/592612b7a54be2c4ddf6446c1c2a8b9a9f5f1e53.
8. Amna Khalid, Sadaf Nasir, Uzma Ali, Maham Khalid, Saadia Anwar and Sameet Jamshed: "Comparison of histopathology (incisional biopsy) vs fine needle aspiration cytology in diagnosing tuberculous cervical lymphadenopathy". Avicenna J of Med Scie 2024, doi: https://www.semanticscholar.org/paper/d295b18a66893332dfad2581580ad9df5fb1290e.
9. Saif A Ghabisha, Saleh Al-wageeh, Fayed Al-Yousofy, Faisal Ahmed, Taha Al-Mwald, Abdulfattah Altam and Mohamed Badheeb: "Utility of perioperative ultrasonography and fine-needle aspiration cytology in differentiation between benign and malignant cervical lymphadenopathy: a retrospective cohort study". Annals of Medicine and Surgery 2024; 3294-3302. doi: https://www.semanticscholar.org/paper/fd4a5701e86c6640f5f25ac0b4d33878b9cc4ee8.
10. Study of Clinicopathological Evaluation of Patients Presenting with Cervical Lymphadenopathy in a Tertiary Care Teaching Hospital. "Study of Clinicopathological Evaluation of Patients Presenting with Cervical Lymphadenopathy in a Tertiary Care Teaching Hospital" 2025; 1-93. doi: https://samwell-prod.s3.amazonaws.com/essay-resource/778162-study-of-clinicopathological-evaluation-of-patients-presenting-with-cervical-lymphadenopathy-in-a-te-23197968.docx.
11. Rita Alaggio, Catalina Amador, Ioannis Anagnostopoulos, Ayoma D. Attygalle, Iguaracyra Araújo, Emilio Berti and Govind Bhagat: "The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms". Leukemia 2022; 1720-1748. doi: https://doi.org/10.1038/s41375-022-01620-2.
12. ÉricOksenhendler, David Boutboul, David C. Fajgenbaum, Adrien Mirouse, Claire Fieschi, Marion Malphettes and Laëtitia Vercellino: "The full spectrum of Castleman disease: 273 patients studied over 20 years"  British Journal of Haematology 2017; 206-216. doi: https://doi.org/10.1111/bjh.15019.
13. B Schmidbauer, Karin Menhart, D. Hellwig and Jirka Grosse: "Differentiated Thyroid Cancer Treatment: State of the Art". International Journal of Molecular Sciences, 2017; 1292-1292. doi: https://doi.org/10.3390/ijms18061292.
14. Yasodha Natkunam, John R. Goodlad, Amy Chadburn, Daphne de Jong, DitaGratzinger, John K. C. Chan and Jonathan W. Said: "EBV-Positive B-Cell Proliferations of Varied Malignant Potential". American Journal of Clinical Pathology 2017; 129-152. doi: https://doi.org/10.1093/ajcp/aqw214.
15. Nicoletta Colombo, Carien L. Creutzberg, FrédéricAmant, Tjalling Bosse, Antonio González-Martı́n, Jonathan A. Ledermann and Christian Marth: "ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: Diagnosis, Treatment and Follow-up". International Journal of Gynecological Cancer 2015; 2-30. doi: https://doi.org/10.1097/igc.0000000000000609.
16. Simone de Campos Vieira Abib, Chan Hon Chui, Sharon Cox, Abdelhafeez H. Abdelhafeez, Israel Fernández‐Pineda, Ahmed Elgendy and Jonathan Karpelowsky: "International Society of Paediatric Surgical Oncology (IPSO) Surgical Practice Guidelines". Ecancermedicalscience 2022, doi: https://doi.org/10.3332/ecancer.2022.1356.
17. Geiger JL, Nofisat Ismaila, Beth M. Beadle, Jimmy J. Caudell, Nicole G. Chau, Daniel G. Deschler and Christine M. Glastonbury: "Management of Salivary Gland Malignancy: ASCO Guideline". Journal of Clinical Oncology 2021; 1909-1941. doi: https://doi.org/10.1200/jco.21.00449.
18. Giulio Cavalli, Serena Colafrancesco, Giacomo Emmi, Massimo Imazio, Giuseppe Lopalco, Maria Cristina Maggio and Jurgen Sota: "Interleukin 1α: a comprehensive review on the role of IL-1α in the pathogenesis and treatment of autoimmune and inflammatory diseases"  Autoimmunity Reviews 2021; 102763-102763. doi: https://doi.org/10.1016/j.autrev.2021.102763.
19. Janelle Guirguis‐Blake, Jillian T. Henderson and Leslie A Perdue: "Periodic screening pelvic examination". JAMA 2017; 954-954. doi: https://doi.org/10.1001/jama.2016.12819.
20. Ji Ye Lee, Jung Hwan Baek, EunJu Ha, Jin Yong Sung, Jung Hee Shin, Ji‐hoon Kim and Min Kyoung Lee: "2020 Imaging guidelines for thyroid nodules and differentiated thyroid cancer: korean society of thyroid radiology". Korean Journal of Radiology 2021; 840-840. doi: https://doi.org/10.3348/kjr.2020.0578.
21. Mahreen Sana, Faheem Mahmood Butt and Adnan Amir: "The Diagnostic Value of Endobronchial Ultrasound-Guided Fine Needle Aspiration (EBUS-FNA) in Diagnosing FDG-PET-Avid Lymph Nodes in Extrapulmonary Malignancies". Cureus 2024, doi: https://www.semanticscholar.org/paper/6884ce7d7a18dc92ef96c5f51c2b4b96c4ccdede.
    

    ---

    How to cite this article:

    Mondal S, Yadav KK, Biswas T, Seth C, Dutta M and Bandopadhyay SN: Study of clinic pathological evaluation of patients presenting with cervical lymphadenopathy in a tertiary care teaching hospital. Int J Pharm Sci & Res 2025; 16(10): 2881-89. doi: 10.13040/IJPSR.0975-8232.16(10).2881-89.

    ---

    All © 2025 are reserved by International Journal of Pharmaceutical Sciences and Research. This Journal licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License.